Back to News
Market Impact: 0.15
CVRx Appoints As John Landry CFO
Source: Nasdaq
Management & GovernanceHealthcare & Biotech
CVRx appointed John Landry as chief financial officer, effective October 12. He succeeds John Oasheim, who will remain with the medical-device company for a transition period; the announcement does not disclose a financial outlook change or operating impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.05
Ticker Sentiment
CVRX0.15
More News
- Paramount agrees invest $1.5 billion in domestic movies and create a board for editorial independence at CNN, CBS as part of deal for Warner Bros.
- Paramount settles with US states in step towards merger with Warner Bros
- GRAIL Stock Bounces Back Above $100: Can Galleri Sail Through Its FDA Panel Review?
- Ra Capital Management sells $21.8m in Sionna Therapeutics shares
- Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production
- Why is Labcorp stock sliding today?